Baby formula can be a life saver in certain situations. Often the meal is expensive to manufacture and the facility itself can also be costly. Not to mention, FDA approval tends to be a waiting game for companies. But it’s an essential one at that to bring safe product to market.

Four companies control a majority of the U.S. production when it comes to infant formula, according to WCNC online. We have Abbott Nutrition, Nestle USA, Perrigo and Mead Johnson Nutrition.

But for the sake of this story, we have focused in on three noteworthy companies that make baby formula.

  1. Else Nutrition (TSX:BABY)
  2. Abbott Laboratories (NYSE:ABT)
  3. Nestle (OTC:NSRGY)

For full details, please watch the above video.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

Join the discussion: Find out what everybody’s saying about baby formula stocks, and check out other hot topics at Stockhouse’s stock forums and message boards.


More From The Market Online

@ the Bell: Stocks rebound into the weekend

The TSX added 0.53% on Friday, ending the week with a 2.17% loss, as investors rekindled risk-on sentiment thanks to a lower oil price.
Oracle jumped 7% on AI cloud demand, lifting the TSX, Dow and Nasdaq, while OpenAI and Anthropic flagged AI risks ahead.

Market Open: Oracle Soars 7% as Markets Rally Despite Oil Above $98 | Sep 11th

Oracle jumped 7% on AI cloud demand, lifting the TSX, Dow and Nasdaq, while OpenAI and Anthropic flagged AI risks ahead.

Promising copper play cleared for solo listing

Copper explorer Blade Resources receives a green light to list its shares on the Canadian Securities Exchange on Monday, September 14th.

StockTalk | Cannabis Report: M&A sparks, insider buys and revenue highs

Curaleaf (TSX:CURA) continues to tout the value it would bring to Aurora Cannabis shareholders, should they agree to an acquisition.